Interestingly, tumor-induced Bregs express high levels of CD80 and CD86, suggesting that CD80 and CD86-mediated contacts between Bregs and their target cells are essential for suppressing T cell response and Bregs-induced Tregs differentiation. The gene discussed is CD86; the disease is neoplasm.